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Abstract  
Objective. A global and systematic review of the available evidence examining the cost of 
work-related stress would yield important insights into the magnitude and nature of this 
social phenomenon. The objective of this systematic review was to collate, extract, review, 
and synthesize economic evaluations of the cost of work-related stress to society. 
Method. A research protocol was developed outlining the search strategy. Included cost-of-
illness (COI) studies estimated the cost of work-related stress at a societal level, and were 
published in English, French or German. Searches were carried out in ingentaconnect, 
EBSCO, JSTOR, Science Direct, Web of Knowledge, Google and  
Google scholar. Included studies were assessed against ten COI quality assessment criteria. 
Results. Fifteen COI studies met the inclusion criteria and were reviewed. These originated 
from Australia, Canada, Denmark, France, Sweden, Switzerland, the United Kingdom, the 
United States, and the EU-15. At a national and pan-European level, the total estimated cost 
of work-related stress in 2014 was observed to be considerable and ranged substantially 
from US$221.13 million to $187 billion. Productivity related losses were observed to 
proportionally contribute the majority of the total cost of work-related stress (between 70 to 
90%), with healthcare and medical costs constituting the remaining 10% to 30%.   
Conclusion. The evidence reviewed here suggests a sizeable financial burden imposed by 
work-related stress on society. The observed range of cost estimates across studies was 
understood to be attributable to variations in definitions of work-related stress; the number 
and type of costs estimated; and, in how production loss was estimated. It is postulated that 
the cost estimates identified by this review are likely conservative due to narrow definitions 
of work-related stress (WRS) and the exclusion of diverse range of cost components.  
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The Cost of Work-Related Stress to Society: A Systematic Review  
Work-related stress has become a major occupational risk factor in all industrialized 
countries, although comparatively less is known within many newly industrialized and 
developing countries (Kortum, Leka, & Cox, 2010). Much has been written about work-
related stress, and investigations conducted to examine and understand its associated 
human and organizational costs. However, much less attention has been paid to 
understanding the economic burden of this social and occupational phenomenon. Although 
small, this growing area of investigation attests to the substantial financial costs associated 
with psychosocial risks and work-related stress for organizations and national economies 
(Hoel, Sparks & Cooper, 2001; Sultan-Taïeb, Chastang, Mansouri & Niedhammer, 2013).  
For many in the field of Occupational Health Psychology (OHP) and beyond, such 
cost estimates are important (and often highly cited) sources of information. They are 
frequently used to illustrate and communicate the scale and magnitude of the problem and, 
in turn, argue the business case for preventative action (Koopmanschap, 1998; Larg & Moss, 
2011). However, detailed evaluations of these costs have seldom received attention in the 
broader literature; with some frequently cited figures being produced without clear 
specification or transparency in their employed methodology (e.g., American Institute of 
Stress, n.d.). There is now an imperative need for OHP, and indeed allied research fields, to 
develop a stronger empirical understanding of where and how such cost estimates are 
derived. No study to date, to the knowledge of the authors, has attempted to systematically 
collate, summarize, review and critique the available economic estimations of work-related 
stress in the literature. Consequently, the current study aims to address this gap.  
Work-related Stress: Causes and Consequences 
Work-related psychosocial risks are concerned with those aspects of work design 
and the organization and management of work within their social and environmental 
contexts, which have the potential for causing psychological, social or physical harm (Cox, 
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Griffiths & Rial-Gonzalez, 2000). Exposure to psychosocial risks in the workplace (such as 
injustice at work, poor organizational climate, poor decision latitude, insufficient leadership, 
effort-reward imbalance) has been linked to poor mental health (Bonde, 2008; Stansfeld & 
Candy, 2006), increased health impairing behaviors (e.g., increased smoking; Kouvonen, 
Kivimäki, Virtanen, Pentti & Vahtera, 2005), alcohol consumption (Kouvonen et al., 2008), 
poor physical health (e.g., coronary heart disease; Kivimäki et al., 2006; Kuper & Marmot, 
2003), and even death (e.g., cardiovascular mortality; Kivimäki et al., 2002). It has also been 
associated with reduced performance (Sullivan & Bhagat, 1992; Virtanen et al., 2009) and 
poorer safety outcomes in the workplace (Spurgeon, Harrington, & Cooper, 1997; Suzuki et 
al., 2004). Despite the potential risks posed, work-related stress and exposure to 
psychosocial risks remain salient characteristics of the modern workplace (see review by 
Leka & Jain, 2010).  
Results from the Fifth European Working Conditions Survey (Eurofound, 2012) found 
a significant proportion of workers reported being exposed to numerous psychosocial risks, 
for example: 62% of surveyed workers reported working under tight deadlines; 59% at a fast 
pace; 51% experiencing organizational change, and; 24% working more than 40 hours a 
week. A survey of 31 European countries found that 40% of workers felt that stress was not 
handled or managed well in their workplace (EU-OSHA, 2013). Consequently, the increased 
recognition of the significant challenge posed by work-related stress and exposure to 
psychosocial risks within occupational health management is now evident with numerous 
stakeholders (e.g., the European Agency for Safety and Health at Work, governments and 
policymakers, researchers) touting these new and emerging risks as a major and global 
occupational and public health concern (EU-OSHA, 2014; Kortum et al., 2010). 
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Cost-of-illness studies 
Alongside epidemiological statistics on mortality and morbidity, understanding the 
financial cost to society is an important avenue to assess the magnitude and significance of 
a disease as an occupational and public health issue (Leigh, 2006; Tarricone, 2006). The 
economic burden of work-related stress is a growing field of inquiry, evidenced by the 
increasing number of cost-of-illness (COI) studies in this area (LaMontagne, Sanderson & 
Cocker, 2010; Levi & Lunde-Jensen, 1996; Sultan-Taïeb et. al, 2013). COI studies aim to 
estimate the total economic impact of a disease incurred by all relevant stakeholders within 
society (Bloom, Canning, & Sevilla, 2001; Tarricone, 2006). For many in the field of OHP, 
and probably the broader psychological research community, a comprehensive and critical 
understanding of the key methodological components and empirical considerations of COI 
studies is arguably limited; thus, the meaningful understanding and critical examination of 
derived figures could be challenging and, potentially, elusive to many. Therefore, the 
following sections aim to provide a brief descriptive overview of the key components and 
methodological considerations underpinning such studies. 
Methodological approach. COI studies can be broadly grouped into three 
approaches: top-down, bottom-up, and deductive (Drummond, Sculpher, Torrance, O’Brien, 
& Stoddart, 2005; Larg & Moss, 2011). In general, the deductive approach is less commonly 
used than top-down or bottom-up approaches (Giga, Hoel, & Lewis, 2008; Hoel et al., 2001). 
Top-down approaches operate by aggregating portions of resources from a specific disease 
or health problem. This involves identifying the proportion of use within particular health 
services or expenditure by users with a specified disease. For example, Sultan-Taïeb et al. 
(2013) first estimated the number of mental disorders and coronary heart disease cases 
attributable to job strain. The burden of these cases on the total medical, sick leave, and 
value of life costs were then calculated before being aggregated to obtain the total cost of job 
strain. These approaches are only as good as the quality of secondary data sources used, 
and often have difficulty distinguishing group differences in consumption and utilization of 
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health and economic resources (Larg & Moss, 2011). Despite this, top-down approaches are 
typically quicker and easier to conduct than bottom-up approaches as the former often relies 
solely on secondary data (Mogyorosy & Smith, 2005). 
In contrast, bottom-up approaches take the estimated cost per case of work-related 
stress and extrapolate it to the national level. In this instance, medical expenditure and/or 
loss of productivity are costed per person or per case, and then multiplied by the number of 
cases or persons affected (Giga et al., 2008; Larg & Moss, 2011). Its strength lies in the 
possibility of identifying all relevant cost components for each specific case or person 
(Wordsworth, Ludbrook, Caskey & Macleod, 2005). However, the lack of appropriate data 
sources can make thorough calculations time consuming or even, in some case, not feasible 
(Larg & Moss, 2011; Mogyorosy & Smith, 2005). 
Finally, the deductive approach examines the proportion of costs associated with 
work-related stress as obtained from the research literature, and applies this to a total 
estimate of work-related illness or productivity (Giga et al., 2008). For example, if work-
related stress was thought to constitute 10% of the total cost of work-related ill-health 
(estimated to be a hypothetical $100 billion), the estimated costs of stress would, therefore, 
be $10 billion. The strength of the deductive approach lies in its simplicity. The main issue 
with the deductive approach is that it assumes the breakdown and the average cost of work-
related stress are  identical to the average cost of work-related ill-health (EU-OSHA, 1999). 
Epidemiological approach. The interpretation of COI studies is directly influenced by 
the epidemiological perspective adopted and utilized by the study: incidence- or prevalence-
based. The incidence-based approach measures the likely avoided costs if new cases are 
prevented (Larg & Moss, 2011). Such studies sum the estimated lifetime costs that are 
attributable to cases that occur during the defined incident period, following which future 
costs are appropriately adjusted to their present day value (i.e., discounting; Mauskopf, 1998; 
Torgerson & Raftery, 1999). The results derived from such studies can: (i) demonstrate how 
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costs vary with disease duration (Larg & Moss, 2011); (ii) inform planning interventions 
targeted at specific stages (Fiscella, Lee, Davis, & Walt, 2009), and; (iii) can be used to 
inform the calculation of baseline costs for cost-effectiveness studies for interventions 
(Finkelsten & Corso, 2003; Goldstein, Reznik, Lapsley  & Cass, 1986). 
Prevalence-based approaches, in contrast, measure the actual impact of existing 
cases compared with a hypothetical alternative case prevalence (Larg & Moss, 2011). Such 
studies measure disease-attributable costs that occur concurrently with prevalent cases over 
a specific time period (usually one year; Larg & Moss, 2011). This approach is generally 
considered the most appropriate for assessing the total current economic burden of a health 
problem (WHO, 2009) as these studies usually include a cross-section of cases, thus 
capturing the costs at varying stages of disease (Mauskopf, 1998). However, this cross-
section of individuals may also include cases that may not be amenable to intervention. 
Consequently, estimates derived using such an epidemiological approach is generally 
viewed as less reliable for measuring the potential savings from preventative interventions 
(WHO, 2009). 
Cost Components. The economic burden of a given disease or health problem is 
estimated by accounting for the costs typically associated with resource consumption, 
productivity losses, and other ‘intangible’ burdens within a specified group. COI studies can 
comprise of direct, indirect or intangible costs (Dagenais, Caro, & Haldeman, 2008; Luppa, 
Heinrich, Angermeyer, König, & Riedel-Heller, 2007; Molinier et al., 2008). Direct costs refer 
to those that, at least in principle, involve a monetary exchange; and can include medical 
(e.g., hospital admissions, physician fees, and the cost of medication) and non-medical 
costs (e.g., insurance, litigation, or travel expenses; Dagenais et al., 2008; Luppa et al., 
2007). Typically, direct medical costs are the easiest to estimate; and, consequently, the 
most commonly accounted for in many studies. This is likely due to the fact that records are 
kept of such transactions. In contrast, evidence of non-medical costs is comparatively less 
8 
 
well documented or readily available making such costs more difficult to estimate (Dagenais 
et al., 2008; Luppa et al., 2007). 
Indirect costs ascribe an economic value to those costs that do not have a clear 
monetary transfer (Dagenais et al., 2008), and usually relate to productivity losses. 
Examples include the economic implications associated with sickness absence, turnover, 
and presenteeism to name a few (e.g., Béjean & Sultan-Taïeb, 2005; McTernan, Dollard, & 
LaMontagne, 2013). Within COI studies it is highly recommended that non-work related 
productivity losses should also be accounted for in derived cost estimates (e.g., housework, 
voluntary work, and other unpaid productivity work; Larg & Moss, 2011); albeit this is not 
common practice (Molinier et al., 2008). In general, indirect costs are more difficult to 
quantify than direct costs, especially in relation to presenteeism (Dagenais et al., 2008). It 
may be for this reason, therefore, why many COI studies do not include or include only a 
minimal number of indirect costs in their respective calculations. 
Several methods are commonly used to estimate the economic value to these 
indirect productivity losses, including: the human capital method; the friction cost method; the 
loss of potential output, and; the costs of life years lost (see Table 1; Dagenais et al., 2008; 
Hansen, 1993; Meltzer, 1997). These methods often use salary as a proxy for productivity 
which is then multiplied with the period of time where productivity loss occurs (Dagenais et 
al., 2008; Jo, 2014). The difference between methods, however, lies in the duration of time a 
person is considered unproductive. It is important to highlight that considerable academic 
debate exists in regards to which calculation approach is empirically and methodologically 
superior (e.g., Johannesson & Karlsson, 1997). It is beyond the scope of this article to 
provide a meaningful summary of this academic debate; however, the interested reader is 
encouraged to read the following articles for a more detailed discussion (Hutubessy, van 
Tulder, Vondeling, & Bouter, 1999; Johannesson & Karlsson, 1997; Meltzer, 1997; van den 
Hout, 2010). 
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[insert Table 1 here] 
Intangible costs reflect the financial value prescribed to the pain and suffering, and 
the reduced quality of life experienced by the afflicted individual or group of individuals 
(Luppa et al., 2007). One approach to quantifying intangible costs is through willingness-to-
pay (Gafni, 1991). Here, intangible costs are reflected in the financial value people would 
pay to avoid different levels of reduced quality of life brought upon by the disease. Due to the 
difficulty in accurately quantifying these experiences, intangible costs are seldom included in 
COI studies; although, their empirical importance in allowing valid and reliable cost estimates 
is strongly acknowledged within economic and public health fields respectively (HSE, 2011; 
Larg & Moss, 2011).  
Aim of the Current Study  
The central objective of the systematic review was to collate, review and synthesize 
evidence-based economic estimations of the cost of work-related stress in relation to 
societal-level outcomes. More specifically, the systematic review aimed to: (i) describe the 
identified studies; (ii) classify and categorize the identified COI studies according to their 
main objectives and their methodological approach; (iii) provide a critical review on the 
methodology within COI studies; and (iv) to draw key conclusions for future research and 
consider implications for the field of OHP.  
Method  
A scoping review of the literature was conducted prior to the commencement of the 
study. The results informed the development of the research protocol, which was agreed 
upon by the entire research team. The systematic review was informed by the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA; Moher, Liberati, 
Tetzlaff, Altman & The PRISMA Group, 2009) guidelines. 
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Search Strategy 
The databases searched were: ingentaconnect; EBSCO (Academic Search Premier, 
Business Source Premier, PsychArticles, PsychInfo); JSTOR; Science Direct; and Web of 
Knowledge (Medline, Web of Science). Databases were searched on March 18th, 2014, and 
the inclusion period encompassed the start of the database until December 31st, 2013. To 
examine the grey literature, Google and Google Scholar were searched. Root search terms 
(with 14 associated free text variants) were identified in relation to two conceptual 
dimensions: cost ("financial cost", "economic cost", "evaluation cost", "cost-of-illness", “health 
cost”, “productivity cost”) and work-related stress ("effort-reward", "occupational stress", "job 
stress", "work stress", "work-related stress", "job strain", “isostrain”, “iso-strain”). Additional 
articles and research reports were identified by: reviewing websites of NGOs (e.g., WHO), 
governmental departments (e.g., Department of Health), and non-departmental public bodies 
(e.g., UK Health and Safety Executive); examining references cited in identified papers, and; 
contacting subject matter experts. All titles and abstracts identified through the search 
strategy were examined, and relevant articles obtained for assessment. A follow up search of 
the literature was conducted in July 2016. The aim of this search was to identify and consider 
any new articles published during the period between the original search of the literature and 
the point of publication. Only one additional study was identified. 
Articles were required to meet four inclusion criteria: (i) be a COI study with a 
documented methodology; (ii) examine costs associated with work-related stress; (iii) be 
costed at a societal or national level (e.g., costs borne by a national health insurance/ 
service, economy, or government), and; (iv) be published in English, French, or German. No 
restrictions were placed on the approach or methodologies used to obtain the financial figure 
quoted. 
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Data Extraction and Synthesis 
A data extraction form was developed to standardize the extraction and synthesis 
process. This was peer-reviewed and piloted, with received feedback integrated into its 
further development. The finalized form extracted information relating to the study’s 
background methodology, population, costs and sub-costs; and also included a study quality 
assessment checklist used to assess and compare the utilized methodologies. The checklist 
is based upon the ten-item health economic quality checklist (Drummond et al., 2005), which 
has been adapted for use in COI studies (Molinier et al., 2008; Te Ao, 2014).This adapted 
quality checklist has been used by several previous systematic reviews of COI studies 
examining Alzheimer’s disease (Costa et al., 2012), opiate dependence (Doran, 2008), 
prostate cancer (Molinier et al., 2008), and traumatic brain injury (Te Au, 2014). 
Quality Checklist: Criteria and Scoring 
Each study was evaluated against ten criteria outlined in the quality assessment 
checklist (see Appendix I). These criteria critically examined the following methodological 
and conceptual domains: (i) specification of the utilized definition of work-related stress and 
theoretical grounding of the study; (ii) descriptive clarity of epidemiological sources used; 
(iii) detail in the disaggregation of total costs into appropriate sub-costs; (iv) transparency in 
the utilized activity data (i.e., the data linking epidemiological statistics [prevalence or 
incidence statistics] with an appropriate health or work outcome); (v) outlining and critically 
evaluating the nature all cost values used; (vi) identification of unit costs and consideration 
of their given value; (vii) provision of methodological detail of study parameters; (viii) the 
use of discounting (where appropriate); (viiii) the use of sensitivity analysis; and (x) 
presenting the results of the study consistently in relation to the utilized methodology.  
Discounting refers to the adjustment of costs to reflect future costs having less of a 
value than present day costs (Mauskopf, 1998). This analytical procedure should be 
conducted where costs extend over a one year period. Discounting makes current costs 
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and benefits worth more than those occurring in the future. This is as there is an opportunity 
cost to spending money now and a desire to enjoy benefits now rather than in the future 
(Torgerson & Raftery, 1999). The economic models derived by COI studies are complex; 
and, consequently, contain many uncertainties and unknowns. Sensitivity analysis permits 
testing the robustness of the results by varying in range key variables (e.g. prevalence, unit 
costs, etc.; Costa et al., 2012).  
In order to comparatively evaluate the studies, and attempt to rank them accordingly, 
a scoring system was devised. The scoring and ranking system is an adapted version to 
that used by Doran (2008; 2013). A score was given in relation to each specified criteria (0 
= criterion not met; 1 = partially met; 2 = fully met). The score for each criterion were 
summed to provide a composite score for each study. A method of weighting was not used 
in relation to the ten criteria as such an approach has not been used or validated in 
previous COI reviews. Studies were categorized based by their yielded composite score: 
good (aggregated scores between 16 and 20), average (8 to 15), or poor quality (1 to 7; 
Doran, 2008). Each included study was independently rated by two reviewers; and 
differences discussed until consensus was obtained. No studies were excluded based on 
quality as it allowed for an examination of the diverse range of studies examining work-
related stress and their respective empirical and methodological quality.  
Review Process   
The search strategy identified 188 potentially relevant papers: 172 articles from the 
database searches and a further 16 from the non-database searches (see Figure 1). The 
review of identified articles was conducted in a two-stage process: (i) a title and abstract 
review; (ii) and, subsequently, a full-text review. In the first stage, one reviewer (X1) 
assessed the identified titles and abstracts against two criteria: (i) the article must be a COI 
study, and (ii) it must examine work-related stress. After the removal of duplicates (n=20), 
the application of these parameters resulted in the exclusion of 121 articles at this stage of 
the review, including: 73 articles that did not meet one of the two specified criteria, and a 
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further 48 that failed to meet both criteria. To assess the consistency of the study selection 
process, a random selection of 20% of article abstracts (n=38) were reviewed independently 
by two separate reviewers each (X2 and X3). Both were blind to the first reviewer’s decision. 
The observed Cohen’s kappa statistics indicated moderate agreement (McHugh, 2012): k 
=.76 and .71, respectively. Disagreements were resolved through discussion and consensus 
among the research team. In total, 47 articles were short-listed and reviewed in the second 
stage of the review process by one reviewer (X1). All four specified inclusion criteria were 
applied at this stage. A total of 32 articles were excluded: two could not be retrieved, and 30 
did not meet one or more of the set inclusion criteria. Subsequently, a random selection of 
20% of the 46 articles was independently reviewed by X2 and X3 against the inclusion 
criteria. Interrater agreement was observably strong: k=1 and .83. In total, 15 articles were 
included in the review.  
[insert Figure 1]  
Results  
The majority of the articles reviewed were from Western Europe (Denmark, n=13; 
France, n=34-6; Sweden, n=17; Switzerland=110; and, the United Kingdom, n=311-13) with one 
multinational study examining data from across the EU-15 member states14. The remaining 
five studies derived from: Australia (n=31,2,9), Canada (n=115), and the United States8. A 
descriptive summary of the reviewed articles is presented in Table 2. The publication year of 
retrieved articles ranged from 1996 to 2016, with the vast majority published after 2005 
(n=12; 80%). The epidemiological data used to inform the utilized prevalence or incidence 
statistics was also found to range substantially across studies (from 1991/1992 to 2011), with 
the majority of the articles using data collected between 2000 and 2009 (n=10). In order to 
classify and categorize the identified COI studies, the included studies are presented 
according to the approach used: top-down (n=8), bottom-up (n=4), or deductive (n=4).  
[insert Table 2]  
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Standardization of Cost Figures  
The estimated annual costs stated by each study are presented in Table 3. To allow 
for basic comparisons, country specific consumer price indexes were used to inflate total 
cost figures to December 31st, 2014, and then converted to US Dollars using purchase 
power parities (World Bank, 2015a). Using the most recent data available from the World 
Bank (2015b), the average cost per worker was calculated by dividing the total cost with the 
size of the country’s 2014 national labor force. All annual costs, unless otherwise specified, 
are presented in 2014 valued US dollars. 
[insert Table 3]  
[insert Table 4] 
Quality Assessment of Included Studies  
Table 4 describes the ten COI quality assessment criteria and maps each study 
against it. In general, the reviewed studies met the vast majority of the set quality criteria, 
with six studies classed as good2-5,8-9, seven average1,6-7,10-12,14, and two poor13,15. None of 
the studies fully met all of the set quality criteria; albeit two studies partially met all ten. The 
majority of reviewed COI studies were judged as providing a satisfactory account of their 
utilized methodology and epidemiological source of data. In addition, a common analytical 
feature across many of the reviewed studies was discounting and sensitivity analysis. The 
quality assessment criteria that were, comparatively, less commonly met, included: outlining 
a definition of work-related stress; clearly describing how costs were disaggregated; and 
providing a clear account of the source(s) used to derive utilized cost estimates. 
Top-down Studies (n=8)  
Study aims and characteristics. The aims of each individual study are briefly 
described in Table 2. Five national contexts were examined: Australia1,2, Denmark3, France4-
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6, Sweden7, and the United States8. The primary objective of seven studies was to examine 
the financial cost of job strain (defined as high demands and low control) and associated 
illness and ailments. Five of these seven studies focused on specific job strain related 
illnesses, including: depression and mental disorders1,2,4-6, cardiovascular disease4-6, and 
musculoskeletal disorders4,6. The remaining two studies examined job strain specifically. The 
utilized prevalence statistics by these studies ranged between 9% and 27.3%, and were 
obtained using epidemiological data from national and regional epidemiological surveys 
collected between 1991 and 2010. The studies most commonly attempted to calculate the 
cost of job strain drawing on data obtained from the surveys collected within a year of the 
estimations. However, on two occasions the prevalence data was collected from two6-7 years 
earlier. In another instance, the cost of job strain in Denmark for 2005 was based on the 
Danish Health Interview Survey conducted five year earlier (Juel, Sorensen, & Bronnum-
Hansen, 2008). The aim of the eighth study was to examine the financial costs associated 
with ten specified work stressors: being unemployed; having no health insurance; shift work; 
long work hours; job insecurity; work–family conflict; low job control; high job demands; low 
social support; and low organizational justice. Prevalence data were drawn from the 2002, 
2006 and 2010 US General Social Survey, and the 2011 Current Population Survey. Within 
this category of studies, five studies were rated ‘good’2-5,8 with the remaining1,6,7 rated 
‘average’.  
Calculation technique and cost components. Seven1,3-8 of the eight studies 
accounted for one of several healthcare-related direct cost components, with medical care 
the direct cost component most frequently estimated. Other direct cost components 
accounted for, included: antidepressant medication; the use of mental health and primary 
care services; and, ambulatory care. None of studies reviewed accounted for non-healthcare 
related direct costs or intangible costs in their economic estimates.  
Only one study8 did not estimate indirect costs in their economic model. Among the 
remaining seven studies, the most common indirect cost component estimated was 
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sickness absence (n=7). The friction cost method was used by the majority of studies to 
estimates this indirect cost (n=6); whereby the number of sick days observed was multiplied 
with either daily GDP per capita4-6 or wage1-3,7. The remaining study3, however, used the 
human capital method to derive their estimate. The second indirect cost component most 
commonly accounted was early or premature death (n=5). The majority of studies derived 
an estimated cost for early death by using the human capital method; followed by loss-of-
potential-output and cost-of-life-years-lost method. Other indirect costs examined were 
early retirement6,7, turnover1, presenteeism2, and disability pension2; albeit, comparatively, 
less often.  
Findings.The diverse aims and objectives, cost components, and definitions for 
work-related stress within this review are reflected in the wide range of work-related stress 
costs observed (see Table 2). At the national level, the cost of work-related stress ranged 
considerably: Australia ($221.13 -$580.32 million; cost per worker: $17.79 to $46.68), 
Denmark ($379 million to $2.27 billion; $130.07 to $777.26), France ($1.83 to $4.36 billion; 
$60.95 to $145.03); Sweden ($703.12 million; $136.71 per worker); and the United States 
($187 billion; $1211.84). 
Figure 2 illustrates the proportion of the total cost of work-related stress accounted 
for by medical (direct) and production-related (indirect) costs mapped across identified 
studies and calculation techniques. Only five3-7 of the eight studies provided the necessary 
information to examine the proportion of costs. In general, production-related costs 
comprised the largest proportion of the estimated total costs, constituting approximately 70% 
to 90%. Conversely, the remaining 10% to 30% of the estimated costs were borne by the 
healthcare system and associated medical costs. These cost estimates are directly 
influenced by the calculation technique used, and can be attributed to the length of time in 
which loss of production is considered to occur. For example, in Denmark3 a smaller 
estimated loss is observed when production loss is restricted to the first three months of 
leaving the labor market (friction cost method; $374 million), than when it encompasses the 
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duration until expected retirement age (human capital method; $2.24 billion). Similarly, in 
France4, the shorter timeframe of the human capital method yielded a lower cost (€753 
million) in comparison to the cost-of-life-years-lost method (€954 million). 
Bottom-up approaches (n=4)  
Study aims and characteristics. The brief aims of each bottom-up study are 
presented in Table 2, with one study12 limiting their scope to costs arising exclusively from 
sickness absence. Within this category of studies, one was rated good9, with the remaining10-
12 rated as average. A wider variety of definitions of work-related stress are used here 
compared to top-down approaches. Two studies9,10 examined the degree of self-reported 
perceived stress within the given population; while the remaining two studies11,12 defined their 
study by examining ‘stress, depression and anxiety’ inclusively. Three of the studies drew 
upon national surveys and incidence-based statistics examining the frequency of work-
related stress cases9,11 and the number of working days lost12. The data used to inform the 
utilized statistics derived from national-level surveys, all of which collected data in the last 10 
years (2005/200612; 2008/201111; 2009/201010) and within a year of the year being costed by 
the COI analysis. The fourth10 study, set in 1999, obtained their prevalence statistics from a 
survey using their own research sample where data was collected in 199812. Three national 
contexts were examined by those studies categorized as using a bottom-up approach: 
Australia9, Switzerland10 and the United Kingdom11,12. 
Calculation technique and cost components. Three of the bottom-up studies 
calculated the cost of work-related stress9-11 or work-related ill-health10 before multiplying 
with the number of persons with work-related stress. The fourth, by SCMH12 (2007), 
multiplied the number of days due to ‘stress, depression and anxiety’ with the estimated 
average cost per day incurred due to production loss. In general, a wider range of costs are 
included within bottom-up studies compared to the top-down studies. This is a result of the 
COI analyses conducted by the national health and safety agencies of Australia9 and the 
United Kingdom11 being more sensitive and including a broader range of cost components in 
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order to obtain a more accurate national picture of the cost of work-related ill-health. In 
addition to the direct healthcare costs, both these studies examined direct non-healthcare 
costs including: administration, funeral, home, legal, travel and others costs (Table 3). These 
estimates were informed by information derived from various national databases. In contrast, 
Ramaciotti and Perriard10 (2003) used financial information relating to medical services and 
self-medication provided by 150 surveyed individuals. This was used to derive an estimate 
for average cost per case of work-related stress. This aggregated figure was than 
extrapolated to the national sample. 
The majority of indirect costs (specifically, turnover9,11, sickness absence9,10,12, and 
work reorganization11) were estimated using the friction cost method to derive an estimated 
cost; albeit the cost of early retirement was estimated using the human capital method by the 
SafeWork Australia9 study. Intangible costs (i.e., non-financial human costs) were accounted 
for in only one study11 (both within this category of studies and across all reviewed studies) 
conducted by the UK Health and Safety Executive (HSE). This cost component was based 
on information derived from a representative sample on their reported willingness to pay to 
avoid reductions in quality of life resulting from illness or death. 
Findings. Across the studies using a bottom-up approach the total cost of work-
related stress was observed to cost $3.33 billion in Switzerland10 (cost per worker $701.14), 
$3.98 billion in Australia9 ($320.14 per worker), and $5.42 billion in the United Kingdom11 
($164.58 per worker). The COI study that exclusively estimated sickness-related absence 
within the United Kingdom12 observed a cost of $2.18 billion ($66.35 per worker).  
Limited information was provided among the four bottom-down studies regarding the 
observed proportion of cost components associated with the total estimated costs of work-
related stress. Two studies discuss the proportion of costs associated with the estimated 
costs of work-related ill health; rather than work-related stress. The study conducted by the 
HSE observed the non-financial human (i.e., intangible) cost constituted 56% of the total 
costs of work-related ill-health; and SafeWork Australia9 found that indirect costs associated 
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with production loss made-up 86% of the cost of work-related ill-health. However, 
Ramaciotti and Perriard (2003)10 found sickness absences (59.9%) to account for the 
majority of the estimated cost of work-related stress, followed by medical services (31.53%) 
and self-medication (8.57%). 
Deductive approaches (n=3) 
Study aims and characteristics. Within this category of studies, two studies were 
rated as poor13,15 and the third14 of average quality. Table 2 presents the brief aims of each 
individual study. These studies examined Canada15, the United Kingdom13, and the EU1514. 
Two studies defined work-related stress as job strain14,15, and the third examined ‘stress, 
anxiety and depression’ inclusively13. Deductive approaches first obtain the estimated 
overall cost of work-related ill-health. Then, a percentage that represents the proportion of 
costs that are attributable to work-related stress is applied to the overall cost of work-related 
ill-health. The first study13 applied a 35% figure drawn from the UK Labour Force Survey 
(data collected in 2002). The remaining two studies14,15 used estimates derived from the 
same Swedish study (Levi & Lunde-Jensen, 1996), which estimated that 10-25% of work-
related illness costs are associated with work-related stress. Neither study, however, 
explained how these figures from Sweden were estimated. The first of these two studies15 
used both the upper and lower estimate to derive their calculations for the UK context for 
2008. In contrast, the second study did not make clear why only the lower more 
conservative estimate of 10%14 was used to yield an estimate for the EU-15 for 1999.  
Calculation technique and cost components. The cost components used to inform 
the utilized calculations relate directly to those used to estimate the overall cost of work-
related illness. Two studies13,14 did not outline the accounted for cost components or 
considered sub-costs in relation to the utilized figure of work-related illness. The last study15 
specified the cost components considered in the calculation of the total cost of work-related 
illness, including: cost of mental health care, social service, productivity loss, and other 
costs. 
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Findings. At the national level, the estimated cost of work-related stress in Canada15 
ranged from $2.59 to upwards of $9.59 billion, with the estimated cost per Canadian 
worker15 ranging between $131.31 and $486.33. In the UK13 the cost of work-related stress 
was estimated to range from $13.13 to $23.63 billion, approximately $398.10 to $716.58 
per British worker. The cost of work-related stress within the EU-1514 for 2014 was 
estimated to be €26.47 billion. As purchasing power parity for the combined EU-1514 was 
not available, the cost per worker could not be calculated for this study. The proportional 
split between production, medical and other costs are not available as these are calculated 
at the level of the cost of work-related ill-health, not of work-related stress. 
Discussion 
The aim of the current study was to collate, summarize and comparatively evaluate 
COI studies that examined the total cost of work-related stress to society (as expressed in 
US $). The review identified a modest number of such studies. Together these studies were 
drawn from a limited number of national contexts. Their derived economic cost estimates, 
when comparatively assessed, demonstrated a considerable range in relation to this social 
and occupational phenomenon. The total estimated cost of work-related stress was 
observed to range from $221.3 million to upwards of $187 billion (presented figures inflated 
to 2014 US dollars) across identified studies; with the projected cost per working person 
ranging from $17.79 to upwards of $1,211.84. This surprisingly broad range of estimates 
was found across several levels of comparative analysis: internationally, nationally, and by 
methodological approach.  
The broad range of cost estimates observed by the current review does not yield a 
‘clean and simple’ conclusive, or indeed definitive, statement on the nature and scale of the 
‘true’ cost of work-related stress to society. Moreover, this review raises more questions 
than it provides answers to. The current discussion aims to provide an exploratory 
discussion of the possible reasons underpinning the observed complexity and diversity of 
current estimates of the cost of work-related stress to society. It tentatively suggests how 
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such knowledge might frame our interpretation of such figures. Reflecting on such issues of 
complexity and diversity the authors feel that this paper adds value to the development of 
the OHP discipline. Arguably, it starts to provide a conceptual and methodological 
framework within which to understand and critique relevant studies and their associated 
cost estimates.  
The Cost of Work-related Stress: Missing the Global Picture? 
A central focus on the current study was to gain an international perspective on the 
burden of work-related stress to society. However, the vast majority of studies examined 
the European national context (in particular, France and the UK). Beyond Europe, just three 
countries were examined: Australia, the United States and Canada. Therefore, examining 
the costs of work-related stress to society from a global perspective is, at this point, difficult 
due to the relatively restricted number of national contexts explored and respective costs 
estimated. As such, this represents a significant gap in the literature. Further research is 
needed to examine the nature and magnitude of this issue in a more diverse sample of 
countries; and, in particular, within developing and newly industrialized economies. 
Understanding the economic impact of a wider range of work-related psychosocial health 
issues is vital to understanding the economic impact to society caused by poor 
psychosocial working conditions; beyond those costs just associated with work-related 
stress. These estimates are vital to supporting a business case for psychosocial risk 
management, and, in turn, encouraging preventive action at policy level.  
Defining and Measuring Work-related Stress  
The discrepancy across observed cost estimates may be partly explained by the 
ways in which work-related stress has been defined, and, in turn, measured across 
reviewed studies (e.g., job strain; work stress; stress, depression and anxiety, etc.). Some 
quantify this phenomenon by the degree of exposure to adverse psychosocial working 
conditions, whilst others used data derived from self-report declarations of the presence or 
absence of the condition stress. Houdmont, Cox and Griffiths (2010) observed a 
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considerable variety in case definitions of work-related stress used among 18 nationally 
representative workforce surveys of British workers. Such definitions were found to vary in 
terms of their theoretical basis, structure and content. Each was associated with a unique, 
and comparatively varied, range of prevalence rates. Consequently, such study design 
considerations will have a direct impact on the level of measurement error observed within 
the utilized epidemiological statistics used to derive such economic estimates. Furthermore, 
it is important to highlight that in many of the studies, analyzed for this paper, the time 
discrepancy between the collection of data and publication of the study is substantive. 
Some such periods were as large as 12 years (Shain et al., 2008) and others as small as 
one year (SCMH, 2007). Therefore, it is important that cost estimates derived must be 
interpreted critically with reference to their respective methodological and historical context.   
Comprehensive Measurement: Cost Categories and Cost Components 
A consideration of the cost components included (and, in turn, not included) by the 
reviewed COI studies yields an important interpretative lens in which to consider the range 
of cost estimates observed. The established view, and considered best practice, is that cost 
components derived from all three cost categories should be included in economic models: 
direct, indirect and intangible costs (Dagenais e al., 2008; Molinier et al., 2008). By doing 
so, a comprehensive and, arguably, more accurate estimate of the financial burden posed 
by work-related stress might be achieved. Among reviewed studies, direct and indirect cost 
components were included in the majority of economic models developed. There was an 
overall tendency to account for medical, sickness absence and early retirement costs. 
However, only one study included intangible costs within their economic model (HSE, 
2013).  
In relation to direct costs, most of the costs components included were related to the 
direct costs associated with healthcare; in particular, those related to diagnosis and 
treatment. Very few studies, however, accounted for the consumption of non-healthcare 
resources like transportation, legal costs, household expenditures, relocating, property 
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losses, and informal care of any kind. In relation to indirect costs (or productivity-related 
costs), two particular costs components were typically absent in many of the economic 
models developed: costs associated with turnover and presenteeism. Preliminary evidence 
suggests that such cost components may carry a sizable monetary value. As a result, the 
omission of such costs may result in a shortfall in the final cost estimates. For example, 
presenteeism has been estimated to cost 1.5 to 10 times more than the sickness absence 
(Goetzel et al., 2004; McTernan et al., 2013; SCMH, 2007).  
The cost components associated with intangible costs are seldom included in 
economic models within this field. This failure is a noted methodological limitation that has 
defined many COI studies in other areas of health research (Larg & Moss, 2011). 
Preliminary research, derived from allied health literature, observe that intangible costs 
constitute a significant, if not overwhelming, proportion of economic estimates. For 
example, 67% of the total cost of underage drinking was related to intangible costs (Miller et 
al., 2006), as was between 45% and 65% of the cost of coronary heart disease (Scott et al., 
1993), and 56% of the total cost of work-related ill-health (HSE, 2013). Arguably, the 
omission of intangible and other important indirect costs within cost estimates of work-
related stress are a sizable conceptual omission; but also potentially a significant (and 
potentially costly) exclusion from derived economic estimates.  
Much of the conceptual focus and definition of intangible costs within the health 
economics literature has almost exclusively defined this cost category in relation to indices 
of quality of life, such as: grief, suffering, pain and loss (HSE, 2011; Larg & Moss, 2011). 
The authors would argue that the concept of intangible costs should be extended to 
consider indices related to the quality of working life, such as: job satisfaction, work 
engagement, fulfilling and meaningful work, and so on. The inclusion of such additional 
intangible cost components is of critical importance in deriving a comprehensive and holistic 
economic model of the total cost of work-related stress. In turn, it should ensure a cost 
figure more representative of the financial burden posed by this phenomenon.  
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In summary, a relatively narrow range of cost components were accounted for by 
the studies included in this review. The authors conclude that the available cost estimates 
yield no more than a tentative ‘snap-shot’ of the likely financial burden of work-related 
stress to society. While such ‘snap-shots’ may have some theoretical and practical value, 
they can provide only an approximation of the financial burden posed by work-related 
stress. The importance of critically reflecting on the nature and monetary impact of cost 
components, excluded within many economic models, is highlighted as a key area of 
consideration by the current review. Their importance lies not only in terms of the likely 
direct implication in terms of cost estimates, but also in terms of the design of future COI 
studies within this field. Particular concern is expressed here in relation to indirect costs 
and, particularly, those related to quality of working life. In some cases such cost 
components constitute a sizable proportion of the estimated total cost; and, therefore, their 
exclusion may suggest that the reviewed cost estimates are at best conservative and at 
worst a gross underestimation.  
Methodological Limitations of the Current Systematic Review  
Two methodological limitations should be considered in relation to this review. 
Firstly, by restricting the search strategy to articles in English, German and French, 
potentially relevant studies in Dutch (e.g., Blatter, Houtman, van den Bossche, Kraan & van 
den Heuvel, 2005; Konigsveld et al., 2003) and Spanish (e.g., UGT, 2013) were excluded. 
Therefore, the inclusion of wider spectrum of languages might have revealed a larger 
sample of articles and from a more diverse set of national contexts. Secondly, the 
adjustments made to obtain the average cost of work-related stress per economically active 
person only permits a crude form of comparison between studies; and should, be 
interpreted with a healthy degree of caution.  
 
Conclusion 
“The truth is rarely pure and never simple” Oscar Wilde (1986; 1.1.87). 
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The review concludes that examining the costs of work-related stress to society 
from an international perspective is, at this point in time, difficult. This is due to the 
restricted number of national contexts able to be explored, and to the observed diversity 
across studies in terms of their conceptual and methodological approaches. What is certain 
is that cost estimates for work-related stress should not be taken at face value. Critical 
understanding of their context and the methodology used is paramount. Such cost 
estimates only provide a context-dependent ‘snap-shot’ of the estimated financial burden 
posed by work-related stress and are not without their methodological limitation. These 
estimates do, however, act as an important catalyst in encouraging necessary debate in 
OHP and further afield in research, policy and practice. Such cost figures can act as 
important ‘conversational guesstimates’ highlighting the respective burden posed by work-
related stress to society at large. While the search for the ‘true’ cost of work-related stress 
remains an on-going question, the methodological aspects and considerations of this quest 
for the ‘holy grail’ is of value in the dialogue it stimulates.  
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Table 1: Methods for estimating loss of productivity 
Method Duration of Time Where Production 
Loss Occurs 
Basic Formula for Productivity 
Loss 
Human 
Capital  
Loss of productivity of a worker is the period of 
time between when the worker exits the workforce 
due to illness or premature death, and the time 
they naturally would have exited the workforce 
(i.e., retirement).  
(Mean retirement age – Age when worker 
left workforce) X Annual salary 
Friction Cost  Productivity is only affected in the period it takes 
someone from the unemployed pool to replace the 
performance of the worker. The longer it takes to 
replace a worker, or the longer a worker is absent 
from work, the higher the cost incurred.  
(Time it takes to recruit and train a 
replacement) X annual salary 
Loss-of-
Potential-
Output  
(Hansen, 
1993) 
Like the human capital method, the period of 
production loss used by loss-of-potential-output 
method encompasses the time from early 
retirement or death, until the expected retirement 
age. However, this method involves an implicit 
weighting so that long-term absence results in a 
bigger loss of potential output. This means that 
inability to work among young workers is weighed 
more heavily than among elderly workers 
(Mean retirement age – Age when worker 
left workforce) X Annual salary X 
Weighting value 
Cost-of-Life-
Years-Lost 
(Meltzer, 
1997) 
Individuals make productive contributions to 
society even in retirement. Therefore, the period of 
an individual’s production loss ranges from when 
they exited to the workforce until their mean life 
expectancy. 
(Mean life expectancy – Age when 
worker left workforce) X annual salary 
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Table 2: Overview of study aims and sample backgrounds 
Study Country Definition Brief Aim  
Survey (Year 
collected)  
Work-related Stress 
Incidence/ Prevalence 
Approach 
Top-down approach 
 
1
LaMontagne et 
al. (2010) 
Australia Job Strain 
To estimate the costs in the Australian 
workforce for job strain-attributable 
depression versus all other depression, as 
an indication of the potential economic 
benefit 
Australian National 
Survey of Mental 
Health and 
Wellbeing (2007) 
18.6% (Male) & 25.5% 
(Female) experience Job 
Strain 
Prevalence-
based; 
Incidence-
based 
2
McTernan et al. 
(2013) 
Australia 
Job Strain 
with bullying 
To estimate the contribution of job strain and 
bullying to depression-related loss in 
productivity 
Australian 
Workplace 
Barometer (2009-10) 
22.5% experience Job Strain 
Prevalence-
based 
3
Juel et al. (2008)  Denmark Job Strain 
To calculate the annual resource 
consumption in the health service, and 
production loss attributable to ill-health 
related to psychosocial job strain 
Danish Health 
Interview Survey 
(2000) 
2% experience Job Strain 
Prevalence-
based 
4
Béjean & Sultan-
Taieb (2005)  
France  Job Strain 
To evaluate the costs of work-related stress 
in France related to CVD, depression, and 
MSD, using two methodological hypotheses 
Third European 
Survey on Working 
Conditions (2000) 
20.8% (Male) & 13.6% 
(Female) experience Job 
Strain 75% of the time Prevalence-
based  27.3% (Male) & 17% 
(Female) experience Job 
Strain 50% of the time 
5
Sultan-Taïeb et 
al. (2013) 
France Job Strain 
To estimate the costs of CVDs and mental 
disorders, attributable to job strain exposure 
in France in 2003 from a societal 
perspective 
French Medical 
Monitoring of Risks 
Survey (2003) 
23.2% experience Job Strain 
Prevalence-
based 
6
Trontin et al. 
(2010) 
France Job Strain 
To assess the social cost of job stress on a 
national scale.  
Fourth European 
Survey on Working 
Conditions (2005) 
10.6% (Male) & 12.4% 
(Female) experience Job 
Strain 
Prevalence-
based 
7
Levi & Lunde-
Jensen (1996) 
Sweden Job Strain 
To develop a model for assessing the costs 
of stress at work at a national level. 
First European 
Survey of the 
Working 
Environment (1991-
92) 
9-12% (Male) & 9-11% 
(Female) experience Job 
Strain 
Prevalence-
based 
8
Goh et al. (2016)
 United 
States 
Workplace 
Stressors 
To estimate the aggregate contribution of 
ten specific workplace factors to overall 
mortality and health spending in the United 
States 
The General Social 
Survey (2002, 2006, 
2010) 
7.9-17.4% (Male) & 9.3-34.5% 
(Female) experience 
workplace stressors 
Prevalence-
based 
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Bottom-up approach 
 
9
SafeWork 
Australia (2012)  
Australia 
Mental 
stress 
To estimate the cost of work-related injury 
and illness to Australia 
Australian Work 
Related Injuries 
Survey (2009-10) 
n/a 
Incidence-
based 
10
Ramaciotti & 
Perriard (2003) 
Switzerland 
Stress in 
working 
population 
To investigate the extent of the stress in the 
working Swiss population and the costs 
incurred. 
Survey part of study 
(1998) 
26.6% report feeling stressed 
Prevalence-
based 
11
HSE (2013)  
United 
Kingdom 
Stress, 
Depression 
& Anxiety 
To cost, the injury and ill health outcomes 
associated with health and safety working 
conditions 
UK Labour Force 
Survey (2008-11) 
222,000 number of cases 
Incidence-
based 
12
SCMH (2007) 
United 
Kingdom 
Stress, 
Depression 
& Anxiety 
To identify and quantify all the key effects of 
mental ill health and stress at work 
UK Self-Reported 
Work-Related Illness 
(2005-06) 
10.5 million working days lost 
due to 'stress, depression & 
anxiety' 
Incidence-
based 
       
Deductive approach 
 
13
Chandola 
(2010)  
United 
Kingdom 
Work stress 
To assess the economic cost of work stress 
to Britain 
UK Labour Force 
Survey (2002) 
35% of all health complaints 
Prevalence-
based 
14
European 
Commission 
(2000)  
EU-15 
Member 
States 
Work-related 
stress 
To provide a global attempt to estimate the 
societal costs for work-related stress at a 
European level. 
Levi & Lunde-
Jensen from 
Sweden (1996) 
10% of all health complaints 
Prevalence-
based 
15
Shain et al. 
(2008) 
Canada 
Psychosocial 
hazards 
To estimate the money per annum saved by 
discretionary modifications to the 
organization and management of work to 
make it less injurious to employee mental 
health 
Levi & Lunde-
Jensen from 
Sweden (1996) 
10-25% of all health 
complaints 
Prevalence-
based 
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Table 3: Costs of work-related stress 
  
Definition 
Cost (Year 
of Cost) 
2014 USD 
Cost per 
Worker 
Direct Costs 
Indirect Costs 
Intangible 
Costs 
  Healthcare 
Non-
healthcare 
Top-down studies 
        
1
LaMontagne et al. 
(2010); 
Job Strain 
(High 
demands, low 
control) 
AU$730 
million 
(2007) 
$580 million $46.68 
Antidepressant 
medication; Mental 
health-related health 
service use 
 Sickness absence 
(FCM); Turnover (FCM) 
 
Australia 
  
2
McTernan et al. 
(2013); 
Job Strain 
(High 
demands, low 
control) with 
bullying 
$294.5 
million 
(2009) 
$221.13 
million 
$17.79   
Presenteeism (FCM); 
Sickness absence 
(FCM) 
 
Australia 
   
3
Juel et al. (2008); 
Job Strain 
(High 
demands, low 
control) 
DKK 14.64 
billion (2005) 
$245 million- 
1.46 billion 
$130.08- 
777.26 Hospital visits; Primary 
care visits; Premature 
death; Primary care 
 
Pension (FCM/HCM); 
Premature death (FCM/ 
HCM); Sickness 
absence (HCM) 
 
Denmark DKK 2.45 
billion (2005)     
4
Bejean & Sultan-
Taieb (2005); 
Job Strain 
(High 
demands, low 
control) 
€1.17- 1.62 
billion (2000) 
$1.83- 3.08 
billion 
$60.94- 
102.39 Medical & Ambulatory 
care 
 Premature death (HCM/ 
CLYL); Sickness 
absence (FCM) 
 
France €1.37- 1.97 
billion (2000)     
5
Sultan-Taieb et al. 
(2013); 
Job Strain 
(High 
demands, low 
control) 
€1.84-2.97 
billion (2003) 
$2.7- 4.35 
billion 
$89.85- 
145.03 
Medical (Consumption 
of medical goods and 
services) 
Premature death 
(HCM); Sickness 
absence (FCM) 
 
France 
 
6
Trontin et al. (2010); 
Job Strain 
(High 
demands, low 
control) 
€1.9- 3 
billion (2007) 
$2.54- 4 
billion 
$84.41- 
$133.28 
Medical care 
 
Early death (HCM); 
Retirement (HCM); 
Sickness absence 
(FCM) 
 
France 
 
 
7
Levi & Lunde-
Jensen (1996); 
Job Strain 
(High 
demands, low 
control) 
ECU 450 
million 
(1993) 
$703 million $136.71 
Healthcare and 
rehabilitation costs 
 
Premature death (LPO); 
Retirement (LPO); 
Sickness absence 
(FCM) 
 
Sweden 
 
 
8
Goh et al. (2016); Workplace US$187 $187 billion $1211.84 Medical expenditure    
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United States
 
stressors 
(Layoffs & 
unemployment; 
no health 
insurance; shift 
work; long 
work hours; job 
insecurity, 
work–family 
conflict; low job 
control; high 
job demands; 
low social 
support; low 
org. justice) 
billion (2011) 
Bottom-up studies 
        
9
SafeWork Australia 
(2012); Mental stress 
$5.3 billion 
(2009) 
$3.98 billion $320.14 Medical; Rehabilitation 
Compensation 
& welfare; 
Funeral; 
Investigation; 
Legal; Tax 
loss; Travel; 
Penalties 
Retirement (HCM); 
Sickness absence 
(FCM); Turnover (FCM) 
 
Australia 
 
10
Ramaciotti & 
Perriard (2003); 
Stress in 
working 
population 
CHF 4.19 
billion (1999) 
$3.33 billion $701.14 
Doctor visits; Hospital 
visits; Self-medication 
 Sickness absence 
(FCM) 
 
Switzerland 
  
11
HSE (2013): 
Stress, 
Depression & 
Anxiety 
£3.66 billion 
(2011) 
$5.42 billion $164.58 
NHS treatment and 
rehabilitation; 
Prescription 
Administration; 
Fines; 
Funeral; 
Home; Income 
loss; 
Insurance; 
Travel 
Turnover (FCM); Work 
reorganization (FCM) 
Non-
financial 
human 
costs United Kingdom 
12
SCMH (2007); 
Stress, 
Depression & 
Anxiety 
£1.26 billion 
(2006) 
$2.18 billion $66.35  
 
Sickness absence 
(FCM) 
 
United Kingdom 
 
 
 
Deductive approach 
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13
Chandola (2010); 
Work stress 
(Stress, 
Depression & 
Anxiety) 
£7- 12.6 
billion (2002) 
$13.12- 
23.63 billion 
$398.10- 
716.58 
 
 
Economic 
 
United Kingdom 
  
14
European 
Commission (2000); 
Work-related 
stress 
(High 
demands, low 
control) 
€20 billion 
(1999) 
n/a
a
 
 
 
 
GDP 
 
EU-15 
  
15
Shain et al. (2008); 
Psychosocial 
hazards 
(High 
demands, low 
control) 
$2.97-11 
billion (1998) 
$2.59- 9.59 
billion 
$131.30- 
486.33 
Mental health care 
Social 
services 
Productivity loss 
 
Canada 
  
a
The inability to obtain purchase power parities for the EU as a whole meant it was not possible to convert the inflated Euro cost into US dollars.  
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Table 4: Marks received on quality assessment criteria rating of the fourteen studies   
   Articles 
Approach TD TD TD TD TD TD TD TD BU BU BU BU DD DD DD 
Quality Assessment Criteria 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1. Was a clear definition of the 
illness given? 1 2 2 2 1 1 2 1 0 0 0 0 0 0 0 
2. Were epidemiological 
sources carefully described? 1 2 1 2 2 2 1 2 2 2 2 2 0 1 0 
3. Were costs sufficiently 
disaggregated? 0 0 2 2 2 2 0 2 0 2 0 2 0 0 0 
4. Were activity data 
appropriately assessed? 2 2 2 2 2 2 2 2 2 0 1 2 0 1 0 
5. Were the sources of all cost 
values analytically described? 1 2 2 1 2 0 0 1 2 2 2 0 0 1 0 
6. Were unit costs 
appropriately valued? 1 1 2 1 1 0 1 1 2 2 2 1 0 0 0 
7. Were the methods adopted 
carefully explained? 2 2 2 2 2 0 1 2 2 2 2 2 2 2 2 
8. Were costs discounted? 2 NA 2 2 2 NA 1 NA NA NA 2 NA NA NA NA 
9. Were the major 
assumptions tested in a 
sensitivity analysis? 2 1 2 2 2 1 0 2 2 1 1 0 0 0 2 
10. Was the presentation of 
study results consistent with 
the methodology of study? 1 2 0 2 2 2 1 2 2 2 2 2 0 2 0 
Total Score (Out of 20) 13 16 17 18 18 11 9 17 16 14 14 12 2 8 4 
Study Quality Average Good Good Good Good Average Average Good Good Average Average Average Poor Average Poor 
Legend: 2 marks for fully met criteria; 1 mark for partially met criteria; 0 marks for criteria not met; NA: Not applicable; TD: Top-down; BU: Bottom-up; 
DD: Deductive 
Scoring: 0-7: Poor quality; 8-15: Average quality; 16-20: Good quality.
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Figure 2: Proportion of medical and production loss-related (sickness 
absence, premature death and premature workforce exit) costs 
*Notes: HCM, Human capital method; FCM, Friction cost method; LPO, Loss-of-
potential-output; CLYL, Cost-of-life-years-lost. 
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Appendix: Cost of Illness Study Quality Assessment Checklist 
1. Was a clear definition of the illness given? 
Circle 
correct 
answer 
• Definition of work-related stress (or psychosocial hazard provided) YES/NO 
• Information provided as to how this was measured in the epidemiological / 
prevalence data source (e.g., items used, scoring) 
YES/NO 
Score two if both of the above are met. Score one if only one of 
the above is met. Score zero if none are met.  Score:  
2. Were epidemiological sources carefully described?   
Epidemiological approaches refer to either an incidence or prevalence based 
approach.   
• The source of the epidemiological data is described. This needs to be 
more than just a reference, and allude at the least to sample size and 
geographical location.  
YES/NO 
• Any shortcomings and limitations (e.g., drawing on data from a different 
country) needs to be appropriately justified. 
YES/NO 
Score two if both of the above are met. Score one if only one of 
the above is met. Score zero if none are met. Score:  
3. Were costs sufficiently disaggregated?   
• Are total costs disaggregated (broken) into appropriate sub-costs? 
(Could/ should these costs have been broken down further?) 
YES/NO 
Score two if the above is met. Score zero if it is not met.  Score:  
4. Were activity data appropriately assessed?   
Is data linking stress prevalence/ incidence or stress behaviours with health or 
work outcomes reported? The data can manifest as odds ratios or relative risk, or 
the data demonstrating stressed workers having X amount of sick days or Y 
reduction in productivity. 
 
• Activity data is provided YES/NO 
• Source is provided YES/NO 
Score two if both the above are met. Score one if only one of the 
above is met. Score zero if none are met.  Score:  
5. Were the sources of all cost values analytically described?   
• The source of every cost is provided YES/NO 
• Sampling variation is considered. This means that costs account for 
differences (e.g., gender, age, occupational)  
YES/NO 
Score two if both the above are met. Score one if only one of the 
above is met. Score zero if none are met.  Score:  
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6. Were unit costs appropriately valued?   
• Unit costs are identified (e.g., cost per day, average cost of medication) YES/NO 
• Unit costs are appropriate proxy for the component (i.e., sickness 
absence) 
YES/NO 
• Unit costs sources are provided  YES/NO 
Score two if both the above are met. Score one if one or two the 
criteria above are met. Score zero if none are met.  Score:  
7. Were the methods adopted carefully explained?   
• Study methods were displayed in a clear, transparent manner  YES/NO 
• If a valid and reliable scale/measure was used OR if such scales/measures 
were not used, justification was given for the measures/scales used 
YES/NO 
Score two if both the above are met. Score one if only one of the 
above is met. Score zero if none are met.  Score:  
8. Were costs discounted
1
?   
When costs extend over a one year period, studies should discount 
should be discounted to reflect future costs having less of a value 
than present day costs. The discounting rate needs to be justified 
to fully meet this criterion. 
• Costs extend beyond one year, and cost figures are discounted.  YES/NO 
• Justification for discount rate was provided YES/NO 
Score two if both the above are met. Score one if only one of the 
above is met. Score zero if none are met.  Score:  
9. Were the major assumptions tested in a sensitivity analysis
2
?   
The study should vary in range key variables that may influence outcome (e.g., 
prevalence, unit costs, etc.). Studies with at least 2-way analysis (i.e., change of 
two key variables) fully meet this criteria, those that only vary one key variable only 
partially meet this criterion.  
• 2-way analysis was conducted (i.e., change of two key variables) YES/NO 
• 1-way analysis was conducted (i.e., change of only one key variable) YES/NO 
Score two if a 2-way analysis was conducted. Score one if a 1-way 
analysis was conducted. Score zero if neither was conducted.  Score:  
10. Was the presentation of study results consistent with the methodology of 
study?   
The presentation of COI results should be consistent with collected data and should 
disaggregate results into as many components as possible with full explanations 
given for clarity.  
• Do the results match the aim of the study? YES/NO 
• Are the conclusions made consistent with the results, accounting for the 
methods / sample? 
YES/NO 
Score two if both the above are met. Score one if only one of the 
above is met. Score zero if none are met.  Score:  
Total summed score: [insert] 
Study quality assessment rating [Poor quality (0-7), average quality (8-15), high 
quality (16-20)]: 
[insert] 
                                                
1
 Discounting makes current costs and benefits worth more than those occurring in the future because there is an opportunity 
cost to spending money now and a desire to enjoy benefits now rather than in the future. e.g. If the money was invested 
(wisely) now it would be worth more in one year’s time.   
 
2
 Sensitivity analysis is the standard method of allowing for uncertainty in economic evaluations. It involves varying the values of 
key parameters, one at a time, to see if the results of the evaluation are sensitive to the assumptions made. 
47 
 
 
 
